{
    "organizations": [],
    "uuid": "31c85195c7927c8d05b39bb4bc259f423fd992ba",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-brightpath-biotherapeutics-says-ex/brief-brightpath-biotherapeutics-says-exercise-of-options-idUSL4N1PH2I2",
    "ord_in_thread": 0,
    "title": "BRIEF-BrightPath Biotherapeutics says exercise of options",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - BrightPath Biotherapeutics Co Ltd :\n* Says 4,500 units of its 12th series options were exercised to 450,000 shares of its common stock, during the period from Jan. 16 to Jan. 22\nSource text in Japanese: goo.gl/JHEQvh\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-22T14:40:00.000+02:00",
    "crawled": "2018-01-23T18:07:52.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "brightpath",
        "biotherapeutics",
        "co",
        "ltd",
        "say",
        "unit",
        "12th",
        "series",
        "option",
        "exercised",
        "share",
        "common",
        "stock",
        "period",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}